Stephen John Carter
Chief Executive Officer chez Malaria Research Co. Pty Ltd.
Profil
Stephen John Carter is currently the Chief Executive Officer of Malaria Research Co. Pty Ltd.
He was previously the Chief Executive Officer & Managing Director of Arovella Therapeutics Ltd.
from 2009 to 2019.
Prior to that, he was the Non-Executive Chairman of Holista CollTech Ltd.
from 2006 to 2009.
He also served as Chairman of Delmedica Ltd.
and Director of Solbec Pharmaceuticals Ltd.
Postes actifs de Stephen John Carter
Sociétés | Poste | Début |
---|---|---|
Malaria Research Co. Pty Ltd.
Malaria Research Co. Pty Ltd. BiotechnologyHealth Technology Malaria Research Co. Pty Ltd. develops pharmaceuticals segment for the treatment of malaria. Its product includes ArtiMist, sublingual anti-malarial spray for the treatment of Plasmodium falciparum pediatric malaria. The company is headquartered in Osborne Park, Australia. | Chief Executive Officer | - |
Anciens postes connus de Stephen John Carter
Sociétés | Poste | Fin |
---|---|---|
AROVELLA THERAPEUTICS LIMITED | Chief Executive Officer | 23/09/2019 |
HOLISTA COLLTECH LIMITED | Chairman | 11/11/2009 |
Solbec Pharmaceuticals Ltd. | Director/Board Member | 26/09/2006 |
Delmedica Ltd. | Chairman | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
AROVELLA THERAPEUTICS LIMITED | Health Technology |
HOLISTA COLLTECH LIMITED | Health Technology |
Entreprise privées | 3 |
---|---|
Solbec Pharmaceuticals Ltd. | Health Technology |
Malaria Research Co. Pty Ltd.
Malaria Research Co. Pty Ltd. BiotechnologyHealth Technology Malaria Research Co. Pty Ltd. develops pharmaceuticals segment for the treatment of malaria. Its product includes ArtiMist, sublingual anti-malarial spray for the treatment of Plasmodium falciparum pediatric malaria. The company is headquartered in Osborne Park, Australia. | Health Technology |
Delmedica Ltd. |